Haojia Li

机构：Union Hospital, Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology · ORCID：0009-0008-2396-4562

发表论文 15 篇 · 总被引 182 次 · h-index 5

代表论文

• Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma (2024 · Cell Death Discovery · 被引 110)
• Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer (2023 · BMC Cancer · 被引 22)
• Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer (2025 · Journal of Nanobiotechnology · 被引 19)
• Dual-Multivalent Aptamer-Based Drug Delivery Platform for Targeted SRC Silencing to Enhance Doxorubicin Sensitivity in Endometrial Cancer (2024 · International Journal of Biological Sciences · 被引 10)
• IL-6/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3 (2025 · Cellular Signalling · 被引 5)
• Bavachinin exerts anti-tumor effects by activating TLR4/STING axis-dependent PANoptosis and synergistically enhances chemosensitivity in endometrial cancer (2025 · Biochemical Pharmacology · 被引 4)